TG Therapeutics, Inc. insider trading
This tab shows only the shares insiders bought or sold on the open market in the last twelve months (Form 4 codes P and S). Grants, option exercises, shares held back for tax and gifts are left out on purpose, so what is left is insiders trading at the market price like anyone else.
In the last twelve months insiders at TG Therapeutics, Inc. filed 2 open-market sales worth $437,650 and 0 open-market purchases, on Form 4 with the SEC. The latest: Charney Laurence N, Director, sold 5,000 shares at $54.96 on 10 September 2026, filed 14 September 2026.
| Traded | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 10 September 2026 | Charney Laurence N | Director | Sale | 5,000 | $54.96 | $274,800 | Form 4 |
| 24 November 2025 | Echelard Yann | Director | Sale | 5,000 | $32.57 | $162,850 | Form 4 |
A filing with several lines appears once per line.
Source
Form 4 filings on EDGAR for TG Therapeutics, Inc.: the company's filing index.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.